The FDA approved this therapy in 2010 when there were no other drugs available to treat metastatic castrate-resistant prostate cancer except for docetaxel (Taxotere), a chemotherapy agent. This approval is an example of when desperate times call for desperate measures.
Share this post
The Most Controversial Therapy for Advanced…
Share this post
The FDA approved this therapy in 2010 when there were no other drugs available to treat metastatic castrate-resistant prostate cancer except for docetaxel (Taxotere), a chemotherapy agent. This approval is an example of when desperate times call for desperate measures.